Atlas Trials

Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder

Clinical trial NCT05656534 · COMPLETED

Trial details

NCT number
NCT05656534
Sponsor
Ohio State University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Alcohol Use Disorder
Start date
2022-11-29
Primary completion
2024-08-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.